AddLife AB Stock: price and insider trades · Sweden

This page follows insider dealings at AddLife AB as filed with Finansinspektionen, a company from the Health Care sector. The last twelve months, up to 18 October 2026, brought 14 filings signed by 8 insiders.

Open-market activity splits into 11 purchases totalling €244k and 3 sales totalling €79k; 7 insiders sit on the buying side and 2 insiders on the selling side. On balance, insiders were net buyers of €165k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. One trade stands out by size: a purchase of €86k from Eva Maria Cecilia Sandell Elmstedt, disclosed on 11 June 2026, or 0.0050% of market capitalisation. The buyers include 4 chief executives, 2 board members and 1 finance chief.

In the case of 6 purchases, another manager of the company was buying within the same 30 days. Purchases made close together by different insiders form what is called a cluster. The clock since the last published purchase (27 August 2026) now reads 51 days. Between a trade and the moment it shows up on Finansinspektionen, the median delay is 1 day. For comparison, MAR article 19 gives managers three business days to notify a trade.

With 14 filings in twelve months, the company is more active than the median of 7 filings across the 885 companies we follow on the same exchange. Our records for AddLife AB go back to 2021, with 17 purchases and 6 sales on the open market in total.

Elsewhere in the same sector, our signals recently picked up insider purchases at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from Finansinspektionen. Past trades are no guide to future returns.